| Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer S Wang, RK Kollipara, N Srivastava, R Li, P Ravindranathan, ... Proceedings of the National Academy of Sciences 111 (11), 4251-4256, 2014 | 155 | 2014 |
| Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels N Srivastava, RK Kollipara, DK Singh, J Sudderth, Z Hu, H Nguyen, ... Cell metabolism 20 (4), 650-661, 2014 | 115 | 2014 |
| Oncogenes activate an autonomous transcriptional regulatory circuit that drives Glioblastoma et al. Dinesh Singh, Rahul Kollipara, Vamsidara Vemireddy, Xiao-Li Yang ... Cell Reports 18 (4), 961-976, 2017 | 91 | 2017 |
| The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. KR Wang S, Kollipara RK, Humphries CG, Ma SH, Hutchinson R, Li R, Siddiqui J ... Oncotarget 7 (40), 64921-64931, 2016 | 54 | 2016 |
| RPL41, a small ribosomal peptide deregulated in tumors, is essential for mitosis and centrosome integrity S Wang, J Huang, J He, A Wang, S Xu, SF Huang, S Xiao Neoplasia 12 (3), 284-IN8, 2010 | 51 | 2010 |
| RUVBL1/RUVBL2 ATPase activity drives PAQosome maturation, DNA replication and radioresistance in lung cancer P Yenerall, AK Das, S Wang, RK Kollipara, LS Li, P Villalobos, J Flaming, ... Cell chemical biology 27 (1), 105-121. e14, 2020 | 48 | 2020 |
| Identification and characterization of MARVELD1, a novel nuclear protein that is down-regulated in multiple cancers and silenced by DNA methylation S Wang, Y Li, F Han, J Hu, L Yue, Y Yu, Y Zhang, J He, H Zheng, S Shi, ... Cancer letters 282 (1), 77-86, 2009 | 39 | 2009 |
| MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma Y Yu, Y Zhang, J Hu, H Zhang, S Wang, F Han, L Yue, Y Qu, Y Zhang, ... Cancer science 103 (4), 716-722, 2012 | 26 | 2012 |
| Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer M Shi, S Wang, Y Yao, Y Li, H Zhang, F Han, H Nie, J Su, Z Wang, L Yue, ... Scientific reports 4 (1), 7545, 2014 | 22 | 2014 |
| Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer S Wang, C Gilbreath, RK Kollipara, R Sonavane, X Huo, P Yenerall, ... Cancer letters 488, 40-49, 2020 | 12 | 2020 |
| MARVELD1 regulates integrin β1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing S Wang, J Hu, Y Yao, M Shi, L Yue, F Han, H Zhang, J He, S Liu, Y Li The International Journal of Biochemistry & Cell Biology 45 (11), 2679-2687, 2013 | 10 | 2013 |
| RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer. Cell Chem Biol 27: 105–121 P Yenerall, AK Das, S Wang, RK Kollipara, LS Li, P Villalobos, J Flaming, ... Environ Res Lett 12, 064008, 2020 | 6 | 2020 |
| 蛋白质的糖组学研究进展 王山， 李钰 细胞生物学杂志 28 (2), 127-131, 2006 | 5 | 2006 |
| Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma S Wang, X Huo, Y Yang, Y Mo, RK Kollipara, R Kittler Cancer Letters 552, 215984, 2023 | 4 | 2023 |
| 应用卵黄免疫球蛋白作为亲和配基分离目的蛋白的研究 王山， 许晓楠， 包永明， 安利佳 离子交换与吸附 19 (002), 175-179, 2003 | 3 | 2003 |
| A17 inhibition of RUVBL1/2 ATPase activity drives immune infiltration and radiosensitizes non-small cell lung cancer P Yenerall, AK Das, S Wang, RK Kollipara, H Li, LS Li, P Villalobos, ... Journal of Thoracic Oncology 15 (2), S17-S18, 2020 | 1 | 2020 |
| Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer S Wang, DN Ekoue, GV Raj, R Kittler Cancer letters 438, 86-96, 2018 | 1 | 2018 |
| Nuclear protein MARVELD1 regulates activity of Rho GTPases and inhibits cell adhesion and cell motility. S Wang, J Hu, F Han, M Shi, J He, S Liu, L Yue, Y Li MOLECULAR BIOLOGY OF THE CELL 22, 2011 | | 2011 |
| 兔抗人MARVELD1多肽多克隆抗体及其制备方法[P] 李钰,王山,胡建燃,韩放史明. CN Patent ZL 201010032464.2, 2010 | | 2010 |
| 核蛋白 MARVELD1 与核质转运受体蛋白 Importinβ1 相互作用的鉴定 王山， 肖晟， 赫杰， 韩放， 李钰 中国生物化学与分子生物学报 8, 735-739, 2009 | | 2009 |
